NeoDynamics Past Earnings Performance
Past criteria checks 0/6
NeoDynamics's earnings have been declining at an average annual rate of -34.7%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been declining at an average rate of 58.3% per year.
Key information
-34.7%
Earnings growth rate
24.0%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -58.3% |
| Return on equity | -225.4% |
| Net Margin | -12,338.9% |
| Next Earnings Update | 01 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How NeoDynamics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1 | -93 | 72 | 0 |
| 30 Sep 23 | 1 | -101 | 78 | 0 |
| 30 Jun 23 | 0 | -91 | 70 | 0 |
| 31 Mar 23 | 0 | -82 | 62 | 0 |
| 31 Dec 22 | 0 | -75 | 55 | 0 |
| 30 Sep 22 | 1 | -68 | 49 | 0 |
| 30 Jun 22 | 1 | -66 | 48 | 0 |
| 31 Mar 22 | 2 | -67 | 47 | 0 |
| 31 Dec 21 | 2 | -69 | 47 | 0 |
| 30 Sep 21 | 4 | -60 | 46 | 0 |
| 30 Jun 21 | 6 | -54 | 47 | 0 |
| 31 Mar 21 | 11 | -41 | 47 | 0 |
| 31 Dec 20 | 17 | -31 | 47 | 0 |
| 30 Sep 20 | 20 | -26 | 35 | 0 |
| 30 Jun 20 | 22 | -24 | 28 | 0 |
| 31 Mar 20 | 23 | -23 | 19 | 0 |
| 31 Dec 19 | 22 | -19 | 9 | 0 |
| 30 Sep 19 | 25 | -21 | 10 | 0 |
| 30 Jun 19 | 24 | -21 | 9 | 0 |
| 31 Mar 19 | 26 | -20 | 9 | 0 |
| 31 Dec 18 | 25 | -18 | 7 | 0 |
| 31 Dec 17 | 11 | -7 | 5 | 0 |
| 31 Dec 16 | 8 | -8 | 4 | 0 |
Quality Earnings: NEOD is currently unprofitable.
Growing Profit Margin: NEOD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEOD is unprofitable, and losses have increased over the past 5 years at a rate of 34.7% per year.
Accelerating Growth: Unable to compare NEOD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEOD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (59.4%).
Return on Equity
High ROE: NEOD has a negative Return on Equity (-225.45%), as it is currently unprofitable.